Основная статистика
| LEI | 549300FGMK4EGHSK8N86 |
| CIK | 1785971 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to BlackRock Health Sciences Term Trust
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| May 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defini |
|
| April 22, 2025 |
BlackRock Health Sciences Term Trust (BMEZ) Announces Final Results of Tender Offer EX-99.1(a)(5)(iii) Exhibit (a)(5)(iii) Contact: 1-800-882-0052 BlackRock Health Sciences Term Trust (BMEZ) Announces Final Results of Tender Offer New York, April 21, 2025 – BlackRock Health Sciences Term Trust (the “Fund”) announced today the final results of the Fund’s tender offer (the “Tender Offer”) for up to 40% of its outstanding common shares (the “Shares”), which expired on April 17, 2025 |
|
| April 22, 2025 |
SC TO-I/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per |
|
| April 22, 2025 |
Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables SC TO-I/A (Form Type) BlackRock Health Sciences Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid — 0. |
|
| April 18, 2025 |
Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables SC TO-I/A (Form Type) BlackRock Health Sciences Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid — 0. |
|
| April 18, 2025 |
SC TO-I/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per |
|
| April 18, 2025 |
Exhibit (a)(5)(ii) Contact: 1-800-882-0052 BlackRock Health Sciences Term Trust (BMEZ) Announces Expiration and Preliminary Results of Tender Offer New York, April 17, 2025 – BlackRock Health Sciences Term Trust (the “Fund”) announced today the expiration and preliminary results of the Fund’s tender offer (the “Tender Offer”) for up to 40% of its outstanding common shares (the “Shares”). |
|
| March 21, 2025 |
Table of Contents Exhibit (a)(1)(i) Offer to Purchase Up to 40% of the Issued and Outstanding Common Shares of Beneficial Interest of BlackRock Health Sciences Term Trust at 99. |
|
| March 21, 2025 |
EX-FILING FEES Calculation of Filing Fee Tables SC TO-I (Form Type) BlackRock Health Science Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid $628,186,745. |
|
| March 21, 2025 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per share (Title of Class of Sec |
|
| March 21, 2025 |
Exhibit (d)(5) Subject to FRE 408 STANDSTILL AGREEMENT This Standstill Agreement (including the exhibits hereto, this “Agreement”) is entered into as of January 20, 2025 by and among Saba Capital Management, L. |
|
| March 21, 2025 |
Exhibit (a)(1)(ii) Letter of Transmittal Regarding Common Shares of Beneficial Interest of BlackRock Health Sciences Term Trust Tendered Pursuant to the Offer to Purchase Dated March 21, 2025 ALL TENDER REQUESTS MUST BE RECEIVED IN PROPER FORM ON OR BEFORE 5:00 P. |
|
| March 21, 2025 |
Exhibit (a)(5)(ii) Contact: 1-800-882-0052 BlackRock Health Sciences Term Trust (BMEZ) Commences Tender Offer for up to 40% of outstanding common shares New York, March 21, 2025 – BlackRock Health Sciences Term Trust (NYSE: BMEZ) announced today the commencement, expiration and pricing dates of the previously announced offer to repurchase up to 40% of outstanding common shares at a price per share equal to 99. |
|
| January 21, 2025 |
EXHIBIT 6 STANDSTILL AGREEMENT This Standstill Agreement (including the exhibits hereto, this "Agreement") is entered into as of January 20, 2025 by and among Saba Capital Management, L. |
|
| January 21, 2025 |
As filed with the Securities and Exchange Commission on January 21, 2025 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| January 3, 2025 |
SC TO-C As filed with the Securities and Exchange Commission on January 2, 2025 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 20, 2024 |
EX-FILING FEES Calculation of Filing Fee Tables SC TO-I/A (Form Type) BlackRock Health Sciences Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid — 0. |
|
| November 20, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per share (Tit |
|
| November 20, 2024 |
Certain BlackRock Funds Announce Final Results of Tender Offers Exhibit (a)(5)(iii) Contact: 1-800-882-0052 Certain BlackRock Funds Announce Final Results of Tender Offers New York, November 19, 2024 – The BlackRock closed-end funds (the “Funds”) listed below announced today the final results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2. |
|
| November 19, 2024 |
Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables SC TO-I/A (Form Type) BlackRock Health Sciences Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid — 0. |
|
| November 19, 2024 |
Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers Exhibit (a)(5)(ii) Contact: 1-800-882-0052 Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers New York, November 18, 2024 – The BlackRock closed-end funds (the “Funds”) listed below announced today the expiration and preliminary results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2. |
|
| November 19, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per share (Tit |
|
| October 16, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per share (Title of Class of Sec |
|
| October 16, 2024 |
Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables SC TO-I (Form Type) BlackRock Health Sciences Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid $44,630,140. |
|
| October 16, 2024 |
Exhibit (a)(1)(ii) Letter of Transmittal Regarding Common Shares of Beneficial Interest of BlackRock Health Sciences Term Trust Tendered Pursuant to the Offer to Purchase Dated October 16, 2024 ALL TENDER REQUESTS MUST BE RECEIVED IN PROPER FORM ON OR BEFORE 5:00 P. |
|
| October 16, 2024 |
Table of Contents Exhibit (a)(1)(i) Offer to Purchase Up to 2.5% of the Issued and Outstanding Common Shares of Beneficial Interest of BlackRock Health Sciences Term Trust at 98% of Net Asset Value Per Share by BlackRock Health Sciences Term Trust in Exchange for Cash THE OFFER TO PURCHASE WILL EXPIRE AT 5:00 P.M., EASTERN TIME, ON NOVEMBER 18, 2024, UNLESS THE OFFER IS EXTENDED. To the Common Sha |
|
| October 11, 2024 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 14)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New Yor |
|
| October 1, 2024 |
As filed with the Securities and Exchange Commission on October 1, 2024 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 21, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per share (Tit |
|
| August 21, 2024 |
EX-FILING FEES Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables SC TO-I/A (Form Type) BlackRock Health Sciences Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid — 0. |
|
| August 21, 2024 |
Certain BlackRock Funds Announce Final Results of Tender Offers EX-99.(a)(5)(iii) Exhibit (a)(5)(iii) Contact: 1-800-882-0052 Certain BlackRock Funds Announce Final Results of Tender Offers New York, August 20, 2024 – The BlackRock closed-end funds (the “Funds”) listed below announced today the final results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2.5% of its outstanding common shares (the “Shares”). The Tender Offers, which expired at 5 |
|
| August 20, 2024 |
Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables SC TO-I/A (Form Type) BlackRock Health Sciences Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid — 0. |
|
| August 20, 2024 |
Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers Exhibit (a)(5)(ii) Contact: 1-800-882-0052 Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers New York, August 19, 2024 – The BlackRock closed-end funds (the “Funds”) listed below announced today the expiration and preliminary results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2. |
|
| August 20, 2024 |
SC TO-I/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0.001 per |
|
| July 18, 2024 |
Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables SC TO-I (Form Type) BlackRock Health Sciences Term Trust (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Transaction Valuation Fee rate Amount of Filing Fee Fees to Be Paid $47,132,551. |
|
| July 18, 2024 |
Discount Management Program Standstill Agreement Exhibit (d)(4) Discount Management Program Standstill Agreement This Discount Management Program Standstill Agreement is entered into as of May 3, 2024 (this “Agreement”), by and among Karpus Management, Inc. |
|
| July 18, 2024 |
Table of Contents Exhibit (a)(1)(i) Offer to Purchase Up to 2.5% of the Issued and Outstanding Common Shares of Beneficial Interest of BlackRock Health Sciences Term Trust at 98% of Net Asset Value Per Share by BlackRock Health Sciences Term Trust in Exchange for Cash THE OFFER TO PURCHASE WILL EXPIRE AT 5:00 P.M., EASTERN TIME, ON AUGUST 19, 2024, UNLESS THE OFFER IS EXTENDED. To the Common Share |
|
| July 18, 2024 |
INVESTMENT MANAGEMENT AGREEMENT Exhibit (d)(2) INVESTMENT MANAGEMENT AGREEMENT AGREEMENT, dated January 24, 2020, between BlackRock Health Sciences Trust II (the “Trust”), a Maryland statutory trust, and BlackRock Advisors, LLC (the “Advisor”), a Delaware limited liability company. |
|
| July 18, 2024 |
Exhibit (a)(1)(ii) Letter of Transmittal Regarding Common Shares of Beneficial Interest of BlackRock Health Sciences Term Trust Tendered Pursuant to the Offer to Purchase Dated July 18, 2024 ALL TENDER REQUESTS MUST BE RECEIVED IN PROPER FORM ON OR BEFORE 5:00 P. |
|
| July 18, 2024 |
SC TO-I 1 d832678dsctoi.htm SC TO-I SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BlackRock Health Sciences Term Trust (Name of Subject Company (Issuer)) BlackRock Health Sciences Term Trust (Names of Filing Person(s) (Issuer)) Common Shares of Beneficial Interest, Par Value $0. |
|
| July 2, 2024 |
SC TO-C As filed with the Securities and Exchange Commission on July 1, 2024 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| June 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 18, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 17, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 14, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 13, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 12, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant x Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 12, 2024 |
BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 11, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant x Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 10, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 7, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| June 4, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| June 3, 2024 |
BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 31, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant x Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 30, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 29, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 24, 2024 |
787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 May 24, 2024 David L. |
|
| May 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 22, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 13)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 Attention: Michael D'Angelo |
|
| May 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 21, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant x Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 21, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BBlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 2) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a- |
|
| May 20, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 20, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 15, 2024 |
DEFC14A CORRESP 787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 May 15, 2024 David L. |
|
| May 14, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 14, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock California Municipal Income Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 13, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☑ Definitive Additional Materials ☐ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 13, 2024 |
CORRESP 787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 May 13, 2024 David L. |
|
| May 10, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☑ Definitive Additional Materials ☐ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 9, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 8, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement þ Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| May 7, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| May 6, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 3, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| May 3, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 2, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant x Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 2, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| May 1, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant x Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Definitive Proxy Statement ☐ Confidential, for Use of the Commission Only (as perm |
|
| April 25, 2024 |
787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 April 25, 2024 VIA EDGAR David Orlic Division of Investment Management Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: Preliminary Proxy Materials on Schedule 14A for the Registrants listed on Appendix A hereto Dear Mr. |
|
| April 25, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e |
|
| April 19, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| April 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ |
|
| April 10, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: þ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| April 9, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6( |
|
| March 21, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement ¨ Definitive Additional Materials þ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| March 11, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement o Definitive Additional Materials þ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 12)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 Attention: Michael D'Angelo |
|
| March 7, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement o Definitive Additional Materials þ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| March 6, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement ¨ Definitive Additional Materials þ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| February 21, 2024 |
Exhibit 1 Saba Capital Management, L.P. (“Saba Capital”), Saba Capital Master Fund, Ltd. (“SCMF”), Boaz R. Weinstein (“Mr. Weinstein,” and together with Saba Capital and SCMF, “Saba”) and the Nominees (as defined below, and together with Saba, the “Participants”) intend to file definitive proxy statements and accompanying forms of proxy with the Securities and Exchange Commission (the “SEC”) to be |
|
| February 21, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant þ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement o Definitive Additional Materials þ Soliciting Material Under Rule 14a-12 BlackRock Health Sciences Term Trust (Name of Registrant as Specified In Its Charter) Saba Capital Management, L. |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 11)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 Attention: Michael D'Angelo |
|
| February 20, 2024 |
EX-3 2 exhibit3.htm EXHIBIT 3 Exhibit 3 Form of Nominee Agreement Saba Capital Management, L.P. 405 Lexington Avenue, 58th Floor New York, NY 10174 [Date] Private & Confidential [Mr./Ms. Nominee] [Address Line 1] [Address Line 2] Dear [Mr./Ms. Nominee]: This will confirm our understanding as follows: You agree that you are willing, should we so elect, to become a member of a slate of nominees (the |
|
| January 31, 2024 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New Yor |
|
| December 26, 2023 |
EX-2 2 exhibit2.htm EXHIBIT 2 Exhibit 2 December 22, 2023 Via Electronic Mail and Courier Ms. Janey Ahn, Secretary c/o Blackrock, Inc. 50 Hudson Yards New York, NY 10001 Re: BlackRock Health Sciences Trust (the "Trust") Dear Ms. Ahn, Saba Capital Management, L.P. ("Saba") is the investment adviser to Saba Capital Master Fund, Ltd. (the "Proponent"), the owner of 3,141,976 shares of common stock, p |
|
| December 26, 2023 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 9)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York |
|
| December 13, 2023 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 8)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York |
|
| December 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 7)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 Attention: Michael D'Angelo ( |
|
| November 20, 2023 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York |
|
| November 8, 2023 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York |
|
| October 24, 2023 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York |
|
| October 16, 2023 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York |
|
| September 22, 2023 |
SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York |
|
| August 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 Attention: Michael D'Angelo ( |
|
| August 4, 2023 |
787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 August 4, 2023 Mr. |
|
| May 26, 2023 |
SC 13D 1 formsc13d.htm FORM SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* BlackRock Health Sciences Term Trust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securities) 09260E105 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 1017 |
|
| May 26, 2023 |
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. |
|
| May 23, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e |
|
| May 8, 2023 |
BLACKROCK HEALTH SCIENCES TERM TRUST Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 25, 2022 |
BlackRock Health Sciences Trust II Schedule of Investments (unaudited) September 30, 2022 BlackRock Health Sciences Trust II (BMEZ) (Percentages shown are based on Net Assets) Security Shares Value Common Stocks Biotechnology — 37. |
|
| June 3, 2022 |
DEF 14A 1 d316120ddef14a.htm CLASSIFIED FUND N&P Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| May 26, 2022 |
Schedule of Investments (unaudited) March 31, 2022 BlackRock Health Sciences Trust II (BMEZ) (Percentages shown are based on Net Assets) Security Shares Value Common Stocks Biotechnology — 32. |
|
| November 24, 2021 |
Schedule of Investments (unaudited) September 30, 2021 BlackRock Health Sciences Trust II (BMEZ) (Percentages shown are based on Net Assets) Security Shares Value Common Stocks Biotechnology — 36. |
|
| July 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e |
|
| June 8, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e |
|
| May 27, 2021 |
Schedule of Investments (unaudited) March 31, 2021 BlackRock Health Sciences Trust II (BMEZ) (Percentages shown are based on Net Assets) Security Shares Value Common Stocks Biotechnology — 33. |
|
| November 25, 2020 |
BlackRock Health Sciences Trust II Schedule of Investments (unaudited) September 30, 2020 BlackRock Health Sciences Trust II (BMEZ) (Percentages shown are based on Net Assets) Security Shares Value Common Stocks Biotechnology — 35. |
|
| June 9, 2020 |
Classified Fund N&P Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 1, 2020 |
BlackRock Health Sciences Trust II Schedule of Investments (unaudited) March 31, 2020 BlackRock Health Sciences Trust II (BMEZ) (Percentages shown are based on Net Assets) Security Shares Value Common Stocks — 77. |
|
| March 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2020 BLACKROCK HEALTH SCIENCES TRUST II (Exact Name of Registrant as Specified in Charter) MARYLAND 811-23466 84-3283144 (State or Other Jurisdiction of Incorporation) (Comm |
|
| January 28, 2020 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-99.(N) 3 d873710dex99n.htm INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT Exhibit (n) CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use of our report dated December 9, 2019 relating to the financial statement of BlackRock Health Sciences Trust II (the “Trust”), which appears in the Statement of Additional Information in the earlier pre-effective registration |
|
| January 28, 2020 |
[LETTERHEAD OF VENABLE LLP] January 28, 2020 Opinion and Consent of Counsel to the Registrant Exhibit (l) [LETTERHEAD OF VENABLE LLP] January 28, 2020 BlackRock Health Sciences Trust II 55 East 52nd Street New York, New York 10055 Re: Rule 462(b) Registration Statement (the “Registration Statement”) relating to the Registration Statement on Form N-2 (1933 Act File No. |
|
| January 28, 2020 |
BMEZ / BlackRock Health Sciences Trust II N-2MEF - - BLACKROCK SCIENCE AND TECHNOLOGY TRUST II BlackRock Science and Technology Trust II As filed with the Securities and Exchange Commission on January 28, 2020 Securities Act Registration No. |
|
| January 24, 2020 |
BMEZ / BlackRock Health Sciences Trust II CORRESP - - BlackRock Health Sciences Trust II Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 January 24, 2020 VIA EDGAR Securities and Exchange Commission Division of Investment Management 100 F Street, N.E. Washington, D.C. 20549 Attn.: Deborah L. O’Neal Attorney, Disclosure Review Office BlackRock Health Sciences Trust II Registration Statement on Form N-2 File Nos. 333-233373; 811-23466 D |
|
| January 24, 2020 |
BMEZ / BlackRock Health Sciences Trust II CORRESP - - BlackRock Health Sciences Trust II BlackRock Health Sciences Trust II 100 Bellevue Parkway Wilmington, DE 19809 January 24, 2020 VIA EDGAR Deborah L. |
|
| January 21, 2020 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 BLACKROCK HEALTH SCIENCES TRUST II (Exact Name of Registrant as Specified in its Charter) Maryland 84-3283144 (State of Incorporation or Organization) (IRS Employer Identification Number) 100 Bellevue Parkway |
|
| December 6, 2019 |
BMEZ / BlackRock Health Sciences Trust II CORRESP - - BlackRock Health Sciences Trust II 787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 December 6, 2019 VIA EDGAR Deborah L. |
|
| August 20, 2019 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-8A NOTIFICATION OF REGISTRATION FILED PURSUANT TO SECTION 8(a) OF THE INVESTMENT COMPANY ACT OF 1940 The undersigned investment company hereby notifies the Securities and Exchange Commission that it registers under and pursuant to the provisions of Section 8(a) of the Investment Company Act of 1940 and in connection with such notific |
